CCL3 and metabolic dysfunction-associated steatotic liver disease: In the obese state, the expression of CCL3 is elevated in both circulating blood and adipose tissues, playing a significant role in the development of Non-alcoholic fatty liver disease (NAFLD), which is induced by diets high in cholesterol and fat [14,94].